Delivery Order SPE2DB20D2104-SPE2DB22FR87A
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $22,530.42 firm-fixed-price delivery order is for the supply of TRIUMEQ 600-50-300 MG TABLET, a medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which covers a wide range of pharmaceutical products and medical supplies...
- This federal contract award, valued at $6,118.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. The contract does not have a set-aside designation, indicating it was awarded through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $84,052.13 firm fixed-price delivery order is for the provision of TRIUMEQ 600-50-300 MG TABLET to support military healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical Division, which...
- This federal contract award, valued at $21,553.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $44,378.98 firm fixed price delivery order is for the provision of TRIUMEQ 600-50-300 MG TABLET, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This single-award...
- This federal contract award, valued at $19,997.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $14,687.55 firm fixed-price contract is for the supply of 4,565,931,042 units of the pharmaceutical product TRIUMEQ TABLET UU 30S. This contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,988.61, is a firm-fixed-price agreement to supply TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, through June 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,341.36 Firm Fixed Price Delivery Order is for TRIUMEQ 600-50-300 MG TABLET pharmaceutical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of TRIUMEQ 600-50-300 MG TABLET medication to the U.S. government. The award, valued at $32,592.64, is a firm fixed price delivery order contract issued by the Defense Logistics Agency (DLA), a defense agency of the Department of Defense (DoD). AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR87ADelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRIUMEQ 600-50-300 MG TABLET in 30-count packages. The $3,326.83 firm-fixed price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, and generic pharmaceuticals, to support military treatment facilities and veterans' healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. AmerisourceBergen's parent company, Cencora, Inc., also holds a separate IDC valued up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 2/17/22 |